FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Muhlestein

Research Profile

Concepts & Ideas

Disorders

Procedures

Coronary Angiography

Chemicals & Drugs

Co-author Network

Publications

TOP 3
James L Januzzi; Rami Alharethi; Kimberly D Brunisholz; Deborah Budge; John F Carlquist; Oxana Galenko; Benjamin D Horne; Stephanie A Moore; Joseph B Muhlestein; Kismet Rasmussen; Gregory L Snow; Abdallah G Kfoury
Interleukin receptor family member ST2 concentrations in patients following heart transplantation.
Heidi T May; John R Nelson; Jeffrey L Anderson; Tami L Bair; Benjamin D Horne; Krishnaji R Kulkarni; Joseph B Muhlestein
A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL3+IDL]).
T Jared Bunch; Brian G Crandall; Jeffrey L Anderson; Tami L Bair; David L Johnson; Donald L Lappe; Heidi T May; Joseph B Muhlestein; Jeffrey S Osborn; J Peter Weiss; John D Day
Intracardiac ultrasound for esophageal anatomic assessment and localization during left atrial ablation for atrial fibrillation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Muhlestein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James L Januzzi; Rami Alharethi; Kimberly D Brunisholz; Deborah Budge; John F Carlquist; Oxana Galenko; Benjamin D Horne; Stephanie A Moore; Joseph B Muhlestein; Kismet Rasmussen; Gregory L Snow; Abdallah G Kfoury
Interleukin receptor family member ST2 concentrations in patients following heart transplantation.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2013;18(3):250-6.
2013: Heidi T May; John R Nelson; Jeffrey L Anderson; Tami L Bair; Benjamin D Horne; Krishnaji R Kulkarni; Joseph B Muhlestein
A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL3+IDL]).
Lipids in health and disease 2013;12():55.
2013: T Jared Bunch; Brian G Crandall; Jeffrey L Anderson; Tami L Bair; David L Johnson; Donald L Lappe; Heidi T May; Joseph B Muhlestein; Jeffrey S Osborn; J Peter Weiss; John D Day
Intracardiac ultrasound for esophageal anatomic assessment and localization during left atrial ablation for atrial fibrillation.
Journal of cardiovascular electrophysiology 2013;24(1):33-9.
2012: Benjamin D Horne; Donald L Lappé; Heidi T May; Joseph B Muhlestein; Jeffrey L Anderson; Tami L Bair; john carlquist
Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiography.
The American journal of cardiology 2012;109(11):1558-62.
2012: Jeffrey L Anderson; Tami L Bair; Stephanie Barton; Kim Brunisholz; Benjamin D Horne; John A Huntinghouse; Stacey Knight; Justin W Mansfield; Chrissa P Mower; Joseph B Muhlestein; Michelle Robinson; Jeffrey S Rollo; Kent M Samuelson; Dustin Siler; Scott M Stevens; Scott C Woller; John F Carlquist
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Circulation 2012;125(16):1997-2005.
2011: Jason M Lappé; Heidi T May; Joseph B Muhlestein; Svati H Shah; Tami L Bair; Deborah Budge; John F Carlquist; Benjamin D Horne; Abdallah G Kfoury; William E Kraus; Donald L Lappé; Rami Alharethi; Jeffrey L Anderson
Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population.
Clinica chimica acta; international journal of clinical chemistry 2011;412(23-24):2094-9.
2011: Joseph B Muhlestein
Chronic infection and coronary atherosclerosis. Will the hypothesis ever really pan out?
Journal of the American College of Cardiology 2011;58(19):2007-9.
2011: Benjamin D Horne; Kurt R Jensen; Abdallah G Kfoury; Donald L Lappé; Heidi T May; Joseph B Muhlestein; Kismet D Rasmusson; Brianna S Ronnow; Brian K Whisenant; Tami L Bair; Kimberly D Brunisholz; Deborah Budge; T Jared Bunch; John F Carlquist; Rami Alharethi; Jeffrey L Anderson
The intermountain risk score predicts incremental age-specific long-term survival and life expectancy.
Translational research : the journal of laboratory and clinical medicine 2011;158(5):307-14.
2011: T Jared Bunch; Brian G Crandall; John D Day; Benjamin D Horne; Donald L Lappe; Joseph B Muhlestein; Jeffrey S Osborn; Jeffrey L Anderson; Samuel J Asirvatham; J Peter Weiss; C Arden Pope
Atrial fibrillation hospitalization is not increased with short-term elevations in exposure to fine particulate air pollution.
Pacing and clinical electrophysiology : PACE 2011;34(11):1475-9.
2011: T Jared Bunch; Brian G Crandall; Jeffrey L Anderson; Tami L Bair; Benjamin D Horne; Donald L Lappe; Heidi T May; Joseph B Muhlestein; Jeffrey S Osborn; J Peter Weiss; John D Day
Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy.
Heart rhythm : the official journal of the Heart Rhythm Society 2011;8(9):1460-6.
2011: Jeffrey L Anderson; Tami L Bair; Benjamin D Horne; Donald L Lappé; Heidi T May; Ryan C Vanwoerkom; Joseph B Muhlestein
Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
American heart journal 2011;162(2):331-339.e2.
2011: Benjamin D Horne; Rami Alharethi; Jeffrey L Anderson; Tami L Bair; Kimberly D Brunisholz; Deborah Budge; John F Carlquist; Jennifer J Connolly; Donald L Lappé; Heidi T May; Torri Metz; Joseph B Muhlestein; James J Park; T Flint Porter; Kismet D Rasmusson; Dale G Renlund; Robert Silver; Josef Stehlik; Abdallah G Kfoury
Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy.
Circulation. Cardiovascular genetics 2011;4(4):359-66.
2011: T Jared Bunch; Brian G Crandall; Jeffrey L Anderson; Tami L Bair; Benjamin D Horne; Donald L Lappe; Heidi T May; Joseph B Muhlestein; Jeffrey S Osborn; J Peter Weiss; John D Day
Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation.
Journal of cardiovascular electrophysiology 2011;22(8):839-45.
2011: Gangadhar Malasana; Heidi T May; Joseph B Muhlestein; Jennifer Nelson; Jeffrey S Osborn; J Peter Weiss; Jeffrey L Anderson; Tami L Bair; Brian G Crandall; John D Day; Donald L Lappe; T Jared Bunch
A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation.
Journal of cardiovascular electrophysiology 2011;22(7):761-6.
2010: Sherman G Sorensen; Heather Aguilar; Wes K McKnight; Heidi Thomas; Joseph B Muhlestein
Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
Journal of interventional cardiology 2010;23(6):575-80.
2010: Benjamin D Horne; Heidi T May; Abdallah G Kfoury; Dale G Renlund; Joseph B Muhlestein; Donald L Lappé; Kismet D Rasmusson; T Jared Bunch; John F Carlquist; Tami L Bair; Kurt R Jensen; Brianna S Ronnow; Jeffrey L Anderson
The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints.
European journal of heart failure 2010;12(11):1203-13.
2010: Jeffrey L Anderson; Heidi T May; Benjamin D Horne; Tami L Bair; Nathaniel L Hall; john carlquist; Donald L Lappé; Joseph B Muhlestein
Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population.
The American journal of cardiology 2010;106(7):963-8.
2010: John F Carlquist; Benjamin D Horne; Chrissa Mower; James Park; John Huntinghouse; Jason T McKinney; Joseph B Muhlestein; Jeffrey L Anderson
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction.
Journal of thrombosis and thrombolysis 2010;30(3):358-64.
2010: Joseph B Muhlestein; Heidi T May; Tami L Bair; Margaret F Prescott; Benjamin D Horne; Richard White; Jeffrey L Anderson
Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.
The American journal of cardiology 2010;106(6):764-9.
2010: Jeffrey L Anderson; Benjamin D Horne; Nicola J Camp; Joseph B Muhlestein; Paul N Hopkins; Lisa A Cannon-Albright; Chrissa P Mower; James J Park; Jessica L Clarke; Zachary P Nicholas; Jason T McKinney; john carlquist
Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease.
American heart journal 2010;160(2):250-256.e3.
2010: Sherman G Sorensen; Heather Aguilar; Walter Reichert; Michael Goldstein; Dennis Thoen; Heidi Thomas; Joseph B Muhlestein
Transient neurological symptoms during contrast transcranial Doppler right-to-left shunt testing in patients with cryptogenic neurological disease.
Journal of interventional cardiology 2010;23(3):284-90.
2010: Heidi T May; Tami L Bair; Donald L Lappé; Jeffrey L Anderson; Benjamin D Horne; John F Carlquist; Joseph B Muhlestein
Association of vitamin D levels with incident depression among a general cardiovascular population.
American heart journal 2010;159(6):1037-43.
2010: T Jared Bunch; J Peter Weiss; Brian G Crandall; Heidi T May; Tami L Bair; Jeffrey S Osborn; Jeffrey L Anderson; Joseph B Muhlestein; Benjamin D Horne; Donald L Lappe; John D Day
Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(4):433-7.
2010: T Jared Bunch; J Peter Weiss; Brian G Crandall; Heidi T May; Tami L Bair; Jeffrey S Osborn; Jeffrey L Anderson; Donald L Lappe; Joseph B Muhlestein; Jennifer Nelson; John D Day
Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians.
Pacing and clinical electrophysiology : PACE 2010;33(2):146-52.
2010: Megan B Smith; Nedra Christensen; Shiquan Wang; Jennifer Strohecker; John D Day; J Peter Weiss; Brian G Crandall; Jeffrey S Osborn; Jeffrey L Anderson; Benjamin D Horne; Joseph B Muhlestein; Donald L Lappe; Heidi Moss; Jessica Oliver; Krista Viau; T Jared Bunch
Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies.
Cardiology 2010;116(1):61-9.
2010: Joseph B Muhlestein
Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients.
Thrombosis and haemostasis 2010;103(1):71-82.
2009: Troy E Madsen; Robert R Pearson; Joseph B Muhlestein; Donald L Lappé; Tami L Bair; Benjamin D Horne; Jeffrey L Anderson
Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography.
Critical pathways in cardiology 2009;8(4):167-71.
2009: Benjamin D Horne; Elizabeth R Hauser; L Wang; Joseph B Muhlestein; Jeffrey L Anderson; John F Carlquist; Svati H Shah; William E Kraus
Validation study of genetic associations with coronary artery disease on chromosome 3q13-21 and potential effect modification by smoking.
Annals of human genetics 2009;73(Pt 6):551-8.
2009: Jeffrey L Anderson; Heidi T May; Tami L Bair; Joseph B Muhlestein; Benjamin D Horne; John F Carlquist
Lack of association of tegaserod with adverse cardiovascular outcomes in a matched case-control study.
Journal of cardiovascular pharmacology and therapeutics 2009;14(3):170-5.
2009: Mark A Crandall; Benjamin D Horne; John D Day; Jeffrey L Anderson; Joseph B Muhlestein; Brian G Crandall; J Peter Weiss; Jeffrey S Osborne; Donald L Lappé; T Jared Bunch
Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
Pacing and clinical electrophysiology : PACE 2009;32(8):981-6.
2009: Benjamin D Horne; Heidi T May; Joseph B Muhlestein; Brianna S Ronnow; Donald L Lappé; Dale G Renlund; Abdallah G Kfoury; John F Carlquist; Patrick W Fisher; Robert R Pearson; Tami L Bair; Jeffrey L Anderson
Exceptional mortality prediction by risk scores from common laboratory tests.
The American journal of medicine 2009;122(6):550-8.
2009: Mark A Crandall; Benjamin D Horne; John D Day; Jeffrey L Anderson; Joseph B Muhlestein; Brian G Crandall; J Peter Weiss; Donald L Lappé; T Jared Bunch
Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
Pacing and clinical electrophysiology : PACE 2009;32(5):648-52.
2009: Heidi T May; Benjamin D Horne; Brianna S Ronnow; Dale G Renlund; Joseph B Muhlestein; Donald L Lappé; Robert R Pearson; John F Carlquist; Abdallah G Kfoury; Tami L Bair; Kismet D Rasmusson; Jeffrey L Anderson
Superior predictive ability for death of a basic metabolic profile risk score.
American heart journal 2009;157(5):946-54.
2009: Benjamin D Horne; Heidi T May; Jeffrey L Anderson; Abdallah G Kfoury; Beau M Bailey; Brian S McClure; Dale G Renlund; Donald L Lappé; John F Carlquist; Patrick W Fisher; Robert R Pearson; Tami L Bair; Ted D Adams; Joseph B Muhlestein
Fasting and other health influences.
The American journal of cardiology 2009;103(7):1042.
2009: T Jared Bunch; Jeffrey L Anderson; Heidi T May; Joseph B Muhlestein; Benjamin D Horne; Brian G Crandall; J Peter Weiss; Donald L Lappé; Jeffrey S Osborn; John D Day
Relation of bisphosphonate therapies and risk of developing atrial fibrillation.
The American journal of cardiology 2009;103(6):824-8.
2008: Benjamin D Horne; John F Carlquist; Joseph B Muhlestein; Tami L Bair; Jeffrey L Anderson
Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease.
Circulation. Cardiovascular genetics 2008;1(2):85-92.
2008: Jeffrey L Anderson; Benjamin D Horne; Matthew J Kolek; Joseph B Muhlestein; Chrissa P Mower; James J Park; Heidi T May; Nicola J Camp; john carlquist
Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility.
American heart journal 2008;156(6):1155-1162.e2.
2008: John M Lasala; David A Cox; David Dobies; Joseph B Muhlestein; John N Katopodis; George Revtyak; Donald S Baim
Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;72(4):433-45.
2008: Benjamin D Horne; Heidi T May; Jeffrey L Anderson; Abdallah G Kfoury; Beau M Bailey; Brian S McClure; Dale G Renlund; Donald L Lappé; john carlquist; Patrick W Fisher; Robert R Pearson; Tami L Bair; Ted D Adams; Joseph B Muhlestein
Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography.
The American journal of cardiology 2008;102(7):814-819.
2008: Amy J Sehnert; Susan E Daniels; Michael Elashoff; James A Wingrove; Christopher R Burrow; Benjamin Horne; Joseph B Muhlestein; Mark Donahue; Stephen B Liggett; Jeffrey L Anderson; William E Kraus
Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
Journal of the American College of Cardiology 2008;52(8):644-51.
2008: John F Carlquist; Jason T McKinney; Zachary P Nicholas; Jessica L Clark; Samera F Kahn; Benjamin D Horne; Joseph B Muhlestein; Heidi T May; Jeffrey L Anderson
Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing.
Journal of thrombosis and thrombolysis 2008;26(1):1-7.
2008: Joseph B Muhlestein
Endothelial dysfunction associated with drug-eluting stents what, where, when, and how?
Journal of the American College of Cardiology 2008;51(22):2139-40.
2008: T Jared Bunch; John D Day; Jeffrey L Anderson; Benjamin D Horne; Joseph B Muhlestein; Brian G Crandall; J Peter Weiss; Donald L Lappe; Samuel J Asirvatham
Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography.
The American journal of cardiology 2008;101(6):848-51.
2008: Abdallah G Kfoury; Thomas French; Benjamin D Horne; Kismet D Rasmusson; Donald L Lappé; Holly L Rimmasch; Colleen A Roberts; R Scott Evans; Joseph B Muhlestein; Jeffrey L Anderson; Dale G Renlund
Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients.
Journal of cardiac failure 2008;14(2):95-102.
2008: Peter J Casterella; James R Revenaugh; James L Burke; Robert R Pearson; Tami L Bair; Heidi T May; Benjamin Horne; Jeffrey L Anderson; Joseph B Muhlestein
Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention.
The Journal of invasive cardiology 2008;20(3):94-8.
2008: Heidi T May; Jeffrey L Anderson; Robert R Pearson; Jonathan R Jensen; Benjamin D Horne; Farangis Lavasani; H Daniel Yannicelli; Joseph B Muhlestein
Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
The American journal of cardiology 2008;101(4):486-9.
2008: Matthew T Rondina; Jason M Lappé; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Benjamin D Horne; Robert R Pearson; Jeffrey L Anderson
Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.
Cardiology 2008;109(3):196-201.
2007: Han-bin Cui; Sheng-huang Wang; Dong-qi Wang; Chang-cong Cui; Xin-yi Chen; Xiao-min Chen; Zheng Zhang; Hong-kao Zhang; Feng Bai; Joseph B Muhlestein
Modified classic risk factors for coronary artery disease in Chinese Han population.
Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 2007;22(4):216-23.
2007: Jeffrey L Anderson; Benjamin D Horne; Scott M Stevens; Amanda S Grove; Stephanie Barton; Zachary P Nicholas; Samera F S Kahn; Heidi T May; Kent M Samuelson; Joseph B Muhlestein; John F Carlquist
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
Circulation 2007;116(22):2563-70.
2007: Anwar Tandar; Christopher M Lehman; George M Rodgers; Kent G Meredith; Joseph B Muhlestein; William H Barry; Andrew D Michaels; Howard R Lee
Activation of coagulation during routine diagnostic coronary angiography.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2007;3(3):345-9.
2007: Benjamin D Horne; John F Carlquist; Joseph B Muhlestein; Zachary P Nicholas; Jeffrey L Anderson
Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study.
American heart journal 2007;154(5):969-75.
2007: Benjamin D Horne; Nicola J Camp; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Zachary P Nicholas; Jeffrey L Anderson
Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
American heart journal 2007;154(4):751-8.
2007: Tami L Bair; Joseph B Muhlestein; Heidi T May; Kent G Meredith; Benjamin D Horne; Robert R Pearson; Qunyu Li; Kurt R Jensen; Jeffrey L Anderson; Donald L Lappé
Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
Circulation 2007;116(11 Suppl):I226-31.
2007: John F Carlquist; Joseph B Muhlestein; Jeffrey L Anderson
Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
Expert review of molecular diagnostics 2007;7(5):511-7.
2007: Jeffrey L Anderson; Brianna S Ronnow; Benjamin D Horne; John F Carlquist; Heidi T May; Tami L Bair; Kurt R Jensen; Joseph B Muhlestein
Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease.
The American journal of cardiology 2007;99(2):169-74.
2007: Kent G Meredith; Benjamin D Horne; Robert R Pearson; Chloe Allen Maycock; Donald L Lappe; Jeffrey L Anderson; Joseph B Muhlestein
Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowing.
The American journal of cardiology 2007;99(2):149-53.
2007: Jeffrey L Anderson; John F Carlquist; William L Roberts; Benjamin D Horne; Heidi T May; Elisabeth L Schwarz; Marzia Pasquali; Rebecca Nielson; Mark M Kushnir; Alan L Rockwood; Tami L Bair; Joseph B Muhlestein
Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
American heart journal 2007;153(1):67-73.
2007: Heidi T May; Rami Alharethi; Jeffrey L Anderson; Joseph B Muhlestein; Sandra P Reyna; Tami L Bair; Benjamin D Horne; Abdallah G Kfoury; John F Carlquist; Dale G Renlund
Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease.
Cardiology 2007;107(3):178-84.
2006: C Arden Pope; Joseph B Muhlestein; Heidi T May; Dale G Renlund; Jeffrey L Anderson; Benjamin D Horne
Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution.
Circulation 2006;114(23):2443-8.
2006: John F Carlquist; Benjamin D Horne; Joseph B Muhlestein; Donald L Lappé; Bryant M Whiting; Matthew J Kolek; Jessica L Clarke; Brent C James; Jeffrey L Anderson
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.
Journal of thrombosis and thrombolysis 2006;22(3):191-7.
2006: Heidi T May; Benjamin D Horne; Jeffrey L Anderson; Robert L Wolfert; Joseph B Muhlestein; Dale G Renlund; Jessica L Clarke; Matthew J Kolek; Tami L Bair; Robert R Pearson; Krishnankutty Sudhir; John F Carlquist
Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
American heart journal 2006;152(5):997-1003.
2006: Heidi T May; Joseph B Muhlestein; John F Carlquist; Benjamin D Horne; Tami L Bair; Beverly A Campbell; Abdallah G Kfoury; Joseph L Lyon; Han Kim; Dale G Renlund
Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
The American journal of cardiology 2006;98(5):653-8.
2006: Benjamin D Horne; Nicola J Camp; Joseph B Muhlestein; Lisa A Cannon-Albright
Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database.
American heart journal 2006;152(2):305-11.
2006: David Aguilar; Marian R Fisher; Christopher M O'Connor; Michael W Dunne; Joseph B Muhlestein; Louis Yao; Sandeep Gupta; Rebecca J Benner; Thomas D Cook; Dearborn Edwards; Marc A Pfeffer
Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease.
American heart journal 2006;152(2):298-304.
2006: Joseph B Muhlestein; Heidi T May; Jonathan R Jensen; Benjamin D Horne; Richard B Lanman; Farangis Lavasani; Robert L Wolfert; Robert R Pearson; H Daniel Yannicelli; Jeffrey L Anderson
The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study.
Journal of the American College of Cardiology 2006;48(2):396-401.
2006: Benjamin D Horne; John F Carlquist; Lisa A Cannon-Albright; Joseph B Muhlestein; Jason T McKinney; Matthew J Kolek; Jessica L Clarke; Jeffrey L Anderson; Nicola J Camp
High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene.
Annals of human genetics 2006;70(Pt 4):524-34.
2006: Thomas B Martins; Jeffrey L Anderson; Joseph B Muhlestein; Benjamin D Horne; John F Carlquist; William L Roberts; John F Carlquist
Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay.
American journal of clinical pathology 2006;125(6):906-13.
2005: Matthew J Kolek; John F Carlquist; Surai Thaneemit; Laura C Lazzeroni; Bryant M Whiting; Benjamin D Horne; Joseph B Muhlestein; Philip W Lavori; Jeffrey L Anderson
The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
Journal of cardiac failure 2005;11(9):677-83.
2005: Bryant M Whiting; Jeffrey L Anderson; Joseph B Muhlestein; Benjamin D Horne; Tami L Bair; Robert R Pearson; John F Carlquist
Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.
American heart journal 2005;150(2):243-50.
2005: Heath U Jones; Joseph B Muhlestein; Kent W Jones; Dale G Renlund; Tami L Bair; T Jared Bunch; Benjamin D Horne; Donald L Lappé; Jeffrey L Anderson; Donald B Doty
Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding.
The Annals of thoracic surgery 2005;80(2):518-22.
2005: Joseph B Muhlestein; Jeffrey L Anderson; ChangZong Cui; YanPing Lan; Tami L Bair; T Jared Bunch; Robert R Pearson; Sherman G Sorensen; Dale G Renlund; Li Zhang; Benjamin D Horne; G Michael Vincent
Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patients.
American heart journal 2005;150(1):182-7.
2005: Benjamin D Horne; Jeffrey L Anderson; Jerry M John; Aaron Weaver; Tami L Bair; Kurt R Jensen; Dale G Renlund; Joseph B Muhlestein
Which white blood cell subtypes predict increased cardiovascular risk?
Journal of the American College of Cardiology 2005;45(10):1638-43.
2005: Steven C Horton; Reza Khodaverdian; Peter Chatelain; Marsha L McIntosh; Benjamin D Horne; Joseph B Muhlestein; James W Long
Left ventricular assist device malfunction: an approach to diagnosis by echocardiography.
Journal of the American College of Cardiology 2005;45(9):1435-40.
2005: Jeffrey L Anderson; Joseph B Muhlestein; Tami L Bair; Steven Morris; Aaron N Weaver; Donald L Lappé; Dale G Renlund; Robert R Pearson; Kurt R Jensen; Benjamin D Horne
Do statins increase the risk of idiopathic polyneuropathy?
The American journal of cardiology 2005;95(9):1097-9.
2005: J Thomas Grayston; Richard A Kronmal; Lisa A Jackson; Alfred F Parisi; Joseph B Muhlestein; Jerome D Cohen; William J Rogers; John R Crouse; Sandra L Borrowdale; Eleanor Schron; Charles Knirsch
Azithromycin for the secondary prevention of coronary events.
The New England journal of medicine 2005;352(16):1637-45.
2005: T Jared Bunch; Joseph B Muhlestein; Tami L Bair; Dale G Renlund; Donald L Lappé; Kurt R Jensen; Benjamin D Horne; Mathew A Carter; Jeffrey L Anderson
Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
The American journal of cardiology 2005;95(7):827-31.
2005: Benjamin D Horne; Jeffrey L Anderson; John F Carlquist; Joseph B Muhlestein; Dale G Renlund; Tami L Bair; Robert R Pearson; Nicola J Camp
Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints.
Annals of human genetics 2005;69(Pt 2):176-86.
2005: Matthew T Rondina; Joseph B Muhlestein
Early initiation of statin therapy in acute coronary syndromes: a review of the evidence.
Journal of interventional cardiology 2005;18(1):55-63.
2005: Brianna S Ronnow; Sandra P Reyna; Joseph B Muhlestein; Benjamin D Horne; Chloe A Allen Maycock; Tami L Bair; John F Carlquist; Abdallah G Kfoury; Jeffrey L Anderson; Dale G Renlund
C-reactive protein predicts death in patients with non-ischemic cardiomyopathy.
Cardiology 2005;104(4):196-201.
2005: Troy E Madsen; Joseph B Muhlestein; John F Carlquist; Benjamin D Horne; Tami L Bair; Jeffrey D Jackson; Jason M Lappe; Robert R Pearson; Jeffrey L Anderson
Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease.
American journal of nephrology 2005;25(1):45-9.
2005: Jessica L Clarke; Jeffrey L Anderson; John F Carlquist; Richard F Roberts; Benjamin D Horne; Tami L Bair; Matthew J Kolek; Chrissa P Mower; Ashle M Crane; William L Roberts; Joseph B Muhlestein
Comparison of differing C-reactive protein assay methods and their impact on cardiovascular risk assessment.
The American journal of cardiology 2005;95(1):155-8.
2004: Matthew J Kolek; John F Carlquist; Joseph B Muhlestein; Bryant M Whiting; Benjamin D Horne; Tami L Bair; Jeffrey L Anderson
Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.
American heart journal 2004;148(6):1034-40.
2004: Jeffrey L Anderson; Chloe A Allen Maycock; Donald L Lappé; Brian G Crandall; Benjamin D Horne; Tami L Bair; Steven R Morris; Qunyu Li; Joseph B Muhlestein
Frequency of elevation of C-reactive protein in atrial fibrillation.
The American journal of cardiology 2004;94(10):1255-9.
2004: Benjamin D Horne; Nicola J Camp; Joseph B Muhlestein; Lisa A Cannon-Albright
Evidence for a heritable component in death resulting from aortic and mitral valve diseases.
Circulation 2004;110(19):3143-8.
2004: Joseph B Muhlestein; Jeffrey L Anderson; Benjamin D Horne; John F Carlquist; Tami L Bair; T Jared Bunch; Robert R Pearson
Early effects of statins in patients with coronary artery disease and high C-reactive protein.
The American journal of cardiology 2004;94(9):1107-12.
2004: Lillian L C Khor; Joseph B Muhlestein; John F Carlquist; Benjamin D Horne; Tami L Bair; Chloe Allen Maycock; Jeffrey L Anderson
Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease.
The American journal of medicine 2004;117(9):657-64.
2004: John F Carlquist; Joseph B Muhlestein; Benjamin D Horne; Noal I Hart; Tobin Lim; Jessica Habashi; Jeffrey G Anderson; Jeffrey L Anderson
Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36.
Atherosclerosis 2004;177(1):53-9.
2004: Jason M Lappé; Joseph B Muhlestein; Donald L Lappé; Rodney S Badger; Tami L Bair; Ruth Brockman; Thomas French; Linda C Hofmann; Benjamin D Horne; Susan Kralick-Goldberg; Nan Nicponski; Janette A Orton; Robert R Pearson; Dale G Renlund; Holly L Rimmasch; Colleen Roberts; Jeffrey L Anderson
Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program.
Annals of internal medicine 2004;141(6):446-53.
2004: Yoshikazu Yazaki; Joseph B Muhlestein; John F Carlquist; Tami L Bair; Benjamin D Horne; Dale G Renlund; Jeffrey L Anderson
A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction.
Journal of cardiac failure 2004;10(4):316-20.
2004: Benjamin D Horne; Joseph B Muhlestein; Donald L Lappé; Dale G Renlund; Tami L Bair; T Jared Bunch; Jeffrey L Anderson
Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease.
Annals of epidemiology 2004;14(2):143-50.
2004: Jeffrey L Anderson; Kurt R Jensen; John F Carlquist; Tami L Bair; Benjamin D Horne; Joseph B Muhlestein
Effect of folic acid fortification of food on homocysteine-related mortality.
The American journal of medicine 2004;116(3):158-64.
2004: Joseph B Muhlestein
Strategies to increase HMG-CoA reductase inhibitor use after acute myocardial infarction.
Drugs & aging 2004;21(9):583-95.
2004: Jeffrey L Anderson; Joseph B Muhlestein
Antibiotic trials for coronary heart disease.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2004;31(1):33-8.
2004: Jeffrey L Anderson; Benjamin D Horne; Heath U Jones; Sandra P Reyna; John F Carlquist; Tami L Bair; Robert R Pearson; Donald L Lappé; Joseph B Muhlestein
Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?
Cardiology 2004;101(4):185-93.
2003: John F Carlquist; Joseph B Muhlestein; Benjamin D Horne; Noal I Hart; Tami L Bair; Henri O F Molhuizen; Jeffrey L Anderson
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
American heart journal 2003;146(6):1007-14.
2003: Joseph B Muhlestein
Antibiotic treatment of atherosclerosis.
Current opinion in lipidology 2003;14(6):605-14.
2003: David B Jessup; Andrew T Coletti; Joseph B Muhlestein; William H Barry; Frederic C Shean; Brian K Whisenant
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003;60(2):180-4.
2003: Christopher M O'Connor; Michael W Dunne; Marc A Pfeffer; Joseph B Muhlestein; Louis Yao; Sandeep Gupta; Rebecca J Benner; Marian R Fisher; Thomas D Cook
Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;290(11):1459-66.
2003: Joseph B Muhlestein; Jeffrey L Anderson
Chronic infection and coronary artery disease.
Cardiology clinics 2003;21(3):333-62.
2003: Jeffrey L Anderson; Joseph B Muhlestein
Restenosis after coronary intervention: narrowing C-reactive protein's prognostic potential?
The American journal of medicine 2003;115(2):147-9.
2003: Joseph B Muhlestein; Jeffrey L Anderson; Benjamin D Horne; Farangis Lavasani; Chloe A Allen Maycock; Tami L Bair; Robert R Pearson; John F Carlquist
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
American heart journal 2003;146(2):351-8.
2003: James S Zebrack; Jeffrey L Anderson; Srinivasan Beddhu; Benjamin D Horne; Tami L Bair; Alfred Cheung; Joseph B Muhlestein
Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?
Journal of the American College of Cardiology 2003;42(1):57-63.
2003: Jeffrey D Jackson; Joseph B Muhlestein; T Jared Bunch; Tami L Bair; Benjamin D Horne; Troy E Madsen; Jason M Lappé; Jeffrey L Anderson
Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization.
American heart journal 2003;145(5):875-81.
2003: Jeffrey L Anderson; John F Carlquist; Benjamin D Horne; Joseph B Muhlestein
Cardiovascular pharmacogenomics: current status, future prospects.
Journal of cardiovascular pharmacology and therapeutics 2003;8(1):71-83.
2003: Benjamin D Horne; Joseph B Muhlestein; John F Carlquist; Tami L Bair; Troy E Madsen; Noal I Hart; Jeffrey L Anderson
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease.
Circulation 2003;107(2):258-63.
2003: Joseph B Muhlestein; Jeffrey L Anderson
Infectious serology and atherosclerosis: how burdensome is the risk?
Circulation 2003;107(2):220-2.
2002: Chloe A Allen Maycock; Joseph B Muhlestein; Benjamin D Horne; John F Carlquist; Tami L Bair; Robert R Pearson; Qunyu Li; Jeffrey L Anderson
Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients.
Journal of the American College of Cardiology 2002;40(10):1777-85.
2002: Srinivasan Beddhu; Kristina Allen-Brady; Alfred K Cheung; Benjamin D Horne; Tami L Bair; Joseph B Muhlestein; Jeffrey L Anderson
Impact of renal failure on the risk of myocardial infarction and death.
Kidney international 2002;62(5):1776-83.
2002: Heath U Jones; Joseph B Muhlestein; Kent W Jones; Tami L Bair; Farangis Lavasani; Mahtab Sohrevardi; Benjamin D Horne; Donald B Doty; Donald L Lappe
Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports.
Circulation 2002;106(12 Suppl 1):I19-22.
2002: onesimus hassan mahdi; Benjamin D Horne; Kelly Mullen; Joseph B Muhlestein; Gerald Byrne
Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease.
Circulation 2002;106(13):1659-63.
2002: Benjamin D Horne; Joseph B Muhlestein; Gunnar G Strobel; John F Carlquist; Tami L Bair; Jeffrey L Anderson
Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention.
American heart journal 2002;144(3):491-500.
2002: Jeffrey L Anderson; Benjamin D Horne; John F Carlquist; Tami L Bair; Jessica Habashi; Noal I Hart; Stephen K Jones; Joseph B Muhlestein
Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery disease.
The American journal of cardiology 2002;90(5):536-9.
2002: T Jared Bunch; Joseph B Muhlestein; Jeffrey L Anderson; Benjamin D Horne; Tami L Bair; Jeffrey D Jackson; Qunyu Li; Donald L Lappé
Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment.
The American journal of cardiology 2002;90(3):299-302.
2002: James S Zebrack; Joseph B Muhlestein; Benjamin D Horne; Jeffrey L Anderson
C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.
Journal of the American College of Cardiology 2002;39(4):632-7.
2002: Jianhui Zhu; Arshed A Quyyumi; Joseph B Muhlestein; F Javier Nieto; Benjamin D Horne; Alexandra Zalles-Ganley; Jeffrey L Anderson; Stephen E Epstein
Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death.
The American journal of cardiology 2002;89(2):155-8.
2002: James S Zebrack; Jeffrey L Anderson; Chloe Allen Maycock; Benjamin D Horne; Tami L Bair; Joseph B Muhlestein
Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
The American journal of cardiology 2002;89(2):145-9.
2002: Joseph B Muhlestein
Secondary prevention of coronary artery disease with antimicrobials: current status and future directions.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2002;2(2):107-18.
2001: D C Duffin; Joseph B Muhlestein; S B Allisson; Benjamin D Horne; R E Fowles; S G Sorensen; J R Revenaugh; Tami L Bair; Donald L Lappe
Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices.
The Journal of invasive cardiology 2001;13(5):354-62.
2001: Joseph B Muhlestein; Benjamin D Horne; Tami L Bair; Qunyu Li; Troy E Madsen; Robert R Pearson; Jeffrey L Anderson
Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.
The American journal of cardiology 2001;87(3):257-61.
2001: Jianhui Zhu; F J Nieto; B D Horne; J L Anderson; Joseph B Muhlestein; Stephen E Epstein
Prospective study of pathogen burden and risk of myocardial infarction or death.
Circulation 2001;103(1):45-51.
2000: Benjamin D Horne; Joseph B Muhlestein; John F Carlquist; Tami L Bair; Troy E Madsen; Noal I Hart; Jeffrey L Anderson
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease.
Journal of the American College of Cardiology 2000;36(6):1774-80.
2000: Joseph B Muhlestein; Benjamin D Horne; John F Carlquist; Troy E Madsen; Tami L Bair; Robert R Pearson; Jeffrey L Anderson
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.
Circulation 2000;102(16):1917-23.
2000: Joseph B Muhlestein; Jeffrey L Anderson; John F Carlquist; K Salunkhe; Benjamin D Horne; Robert R Pearson; T Jared Bunch; A Allen; S Trehan; C Nielson
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.
Circulation 2000;102(15):1755-60.
2000: Jeffrey L Anderson; Jessica Habashi; John F Carlquist; Joseph B Muhlestein; Benjamin D Horne; Tami L Bair; Robert R Pearson; N Hart
A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
Journal of the American College of Cardiology 2000;36(4):1248-52.
2000: Jeffrey L Anderson; Joseph B Muhlestein; Benjamin D Horne; John F Carlquist; Tami L Bair; Troy E Madsen; Robert R Pearson
Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease.
Circulation 2000;102(11):1227-32.
2000: Joseph B Muhlestein
Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events.
Current atherosclerosis reports 2000;2(4):336-41.
2000: H Rosen; Joseph B Muhlestein; John G Bartlett; S Chen; G Chikami; Marshall A Corson; P K Shah; E Gurfinkel; H Hunter Handsfield; L Jackson; Charles Knirsch; Richard A Kronmal; J Allen McCutchan; S Shea
Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease.
The Journal of infectious diseases 2000;181 Suppl 3():S582-4.
2000: Jeffrey L Anderson; Joseph B Muhlestein
The ACADEMIC study in perspective (Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia).
The Journal of infectious diseases 2000;181 Suppl 3():S569-71.
2000: Joseph B Muhlestein
Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
The Journal of infectious diseases 2000;181 Suppl 3():S505-7.
2000: Enrique P Gurfinkel; Gerardo E Bozovich; Branco Mautner; Jeffrey L Anderson; Joseph B Muhlestein; John F Carlquist; A Allen; S Trehan; C Nielson; S Hall; J Brady; M Egger; Benjamin D Horne; Tobin Lim
Chlamydia pneumoniae in coronary artery disease.
Circulation 2000;101(12):E118-9.
2000: Joseph B Muhlestein
Chronic infection and coronary artery disease.
The Medical clinics of North America 2000;84(1):123-48.
1999: Jeffrey L Anderson; Joseph B Muhlestein; Jessica Habashi; John F Carlquist; Tami L Bair; Sidney Elmer; B P Davis
Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.
Journal of the American College of Cardiology 1999;34(6):1778-83.
1999: Joseph B Muhlestein
Animal models of chlamydia and atherosclerosis.
American heart journal 1999;138(5 Pt 2):S514-5.
1999: Jeffrey L Anderson; Joseph B Muhlestein; John F Carlquist; A Allen; S Trehan; C Nielson; S Hall; J Brady; M Egger; Benjamin D Horne; Tobin Lim
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
Circulation 1999;99(12):1540-7.
1999: Jeffrey L Anderson; GJ King; Tami L Bair; Sidney Elmer; Joseph B Muhlestein; Jessica Habashi; L Mixson; John F Carlquist
Association of lipoprotein lipase gene polymorphisms with coronary artery disease.
Journal of the American College of Cardiology 1999;33(4):1013-20.
1999: Jeffrey L Anderson; GJ King; Tami L Bair; Sidney Elmer; Joseph B Muhlestein; Jessica Habashi; John F Carlquist
Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.
Journal of the American College of Cardiology 1999;33(3):727-33.
1999: Joseph B Muhlestein
Fibrin-fibrinogen and dethrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10 Suppl 1():S59-62.
1998: G S Taylor; Joseph B Muhlestein; G S Wagner; Tami L Bair; P Li; Jeffrey L Anderson
Implementation of a computerized cardiovascular information system in a private hospital setting.
American heart journal 1998;136(5):792-803.
1998: Joseph B Muhlestein
Bacterial infections and atherosclerosis.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1998;46(8):396-402.
1998: Jeffrey L Anderson; John F Carlquist; Joseph B Muhlestein; Benjamin D Horne; Sidney Elmer
Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.
Journal of the American College of Cardiology 1998;32(1):35-41.
1998: Jeffrey L Anderson; John F Carlquist; GJ King; L Morrison; M J Thomson; Erwin H Ludwig; Joseph B Muhlestein; Tami L Bair; RH Ward
Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women.
Journal of the American College of Cardiology 1998;31(4):790-6.
1998: Joseph B Muhlestein; Jeffrey L Anderson; Elizabeth H Hammond; L Zhao; S Trehan; E P Schwobe; John F Carlquist
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.
Circulation 1998;97(7):633-6.
1997: Joseph B Muhlestein; LA Karagounis; S Treehan; Jeffrey L Anderson
"Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty.
Journal of the American College of Cardiology 1997;30(7):1729-34.
1997: Jeffrey L Anderson; GJ King; M J Thomson; M Todd; Tami L Bair; Joseph B Muhlestein; John F Carlquist
A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction.
Journal of the American College of Cardiology 1997;30(5):1206-11.
1996: Jeffrey L Anderson; LA Karagounis; Joseph B Muhlestein
Explaining discrepant mortality results between primary percutaneous transluminal coronary angioplasty and thrombolysis for acute myocardial infarction.
The American journal of cardiology 1996;78(8):934-9.
1996: M A Gomez; Jeffrey L Anderson; LA Karagounis; Joseph B Muhlestein; F B Mooers
An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO).
Journal of the American College of Cardiology 1996;28(1):25-33.
1996: Joseph B Muhlestein; Elizabeth H Hammond; John F Carlquist; E Radicke; M J Thomson; LA Karagounis; M L Woods; Jeffrey L Anderson
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.
Journal of the American College of Cardiology 1996;27(7):1555-61.